Does TROFOSFAMIDE Cause Neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Neoplasm progression have been filed in association with TROFOSFAMIDE. This represents 7.3% of all adverse event reports for TROFOSFAMIDE.
8
Reports of Neoplasm progression with TROFOSFAMIDE
7.3%
of all TROFOSFAMIDE reports
2
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm progression From TROFOSFAMIDE?
Of the 8 reports, 2 (25.0%) resulted in death.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TROFOSFAMIDE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TROFOSFAMIDE Cause?
Acute myeloid leukaemia (18)
Myelodysplastic syndrome (18)
Product use in unapproved indication (16)
Off label use (15)
Neutropenia (14)
Anaemia (13)
Dyspnoea (12)
Oedema (10)
Pleural effusion (10)
Hepatosplenomegaly (9)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TROFOSFAMIDE Alternatives Have Lower Neoplasm progression Risk?
TROFOSFAMIDE vs TROPATEPINE
TROFOSFAMIDE vs TROPICAMIDE
TROFOSFAMIDE vs TROSPIUM
TROFOSFAMIDE vs TROSPIUM\XANOMELINE
TROFOSFAMIDE vs TRUVADA